AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
Avita Medical, Inc. (RCEL)
Company Research
Source: GlobeNewswire
VALENCIA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the fourth quarter and full-year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights Commercial revenue increased approximately 50% to $14.1 million compared to the same period in 2022Gross profit margin of 87.3% Full-Year 2023 Financial Highlights Commercial revenue increased approximately 46% to $49.8 million compared to the same period in 2022Gross profit margin of 84.5%As of December 31, 2023, approximately $89.1 million in cash, cash equivalents, and marketable securities “We ended the year with yet another quarter of significant growth, marking a year of extraordinary progress,” said Jim Corbett, AVITA Medical Chief Executive Officer. “In 2023, we successfully executed a series
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- Avita obtains FDA approval for cell harvesting device Recell GO System [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Announces FDA Approval of RECELL GO [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Announces FDA Approval of RECELL GOGlobeNewswire
- AVITA Medical: Financial Challenges Ahead, Despite Innovative RECELL Device [Seeking Alpha]Seeking Alpha
- AVITA Medical to Host Investor Webinar BriefingGlobeNewswire
RCEL
Earnings
- 5/13/24 - Miss
RCEL
Sec Filings
- 6/3/24 - Form 4
- 6/3/24 - Form 4
- 5/30/24 - Form 8-K
- RCEL's page on the SEC website